Until a patch is tested in controlled trials and approved by regulatory agencies, there is no reason to believe it can replicate the effects of true GLP-1 medications
Eli Lilly and Company (2023) A phase 3, open-label study of once daily LY3502970 compared with insulin glargine in adult participants with type 2 diabetes and obesity or overweight at increased cardiovascular risk
At the time of this writing, the child was 2 years old, weighed 11.3 kg [1 standard deviation (SD) below the mean], and was 81.2 cm tall (between 2 and 1 SD below the mean)
It has also been proven crucial in the bodys drug resistance, in particular resistance against anticancer drugs
Cost : Semaglutide can be expensive, especially without insurance coverage, making it less affordable for some people
Effective Weight Loss: Reduces appetite and supports fat burning